Vitamin D3 and skin diseases

Archives of Dermatological Research

Volumn 284, Issue 1 Supplement, 1992, Pages

  Kragballe, K ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

Calcipotriol; Cell proliferation; Psoriasis; T lymphocyte; Vitamin D3

Indexed keywords

CALCIPOTRIOL; CALCITRIOL; COLECALCIFEROL; DRUG DERIVATIVE; VITAMIN D; CALCITRIOL RECEPTOR; CELL NUCLEUS RECEPTOR; TACALCITOL; VITAMIN D DERIVATIVE;

HUMAN; METABOLISM; PSORIASIS; REVIEW; SKIN; AUTOIMMUNITY; BONE MINERALIZATION; CALCIUM ABSORPTION; CALCIUM METABOLISM; CANCER CELL; CANCER THERAPY; CELL DIFFERENTIATION; CELL GROWTH; CONFERENCE PAPER; DOUBLE BLIND PROCEDURE; GENE CONTROL; GROWTH REGULATION; HORMONE ACTION; HYPERCALCIURIA; ICHTHYOSIS; IMMUNOPATHOLOGY; KERATINOCYTE; LYMPHOCYTE ACTIVATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RECEPTOR AFFINITY; SKIN DISEASE; TOPICAL DRUG ADMINISTRATION; VITAMIN D METABOLISM;

CALCITRIOL; CHOLECALCIFEROL; HUMAN; PSORIASIS; SKIN; VITAMIN D;

EID: 0026473196     PISSN: 03403696     EISSN: 1432069X     Source Type: Journal    
DOI: 10.1007/BF00638238     Document Type: Article

References (56)

1. Resistance to 1,25-dihydroxyvitamin D3 of cultured psoriatic epidermal keratinocytes isolated from involved and uninvolved skin
2. Immunosuppressive effects of 1,25-dihydroxyvitamin D3 analogue (calcipotriol) on epidermal cells
3. Receptor mediated rapid action of 1,25-dihydroxy cholecalciferol: increase of intracellular cyclic GMP in human skin fibrolasts
4. Neonatal human foreskin keratinocytes produce 1,25-dihydroxyvitamin D3
5. Effect of a novel vitamin D analogue MC903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivo
6. 20-Epi-vitamin D3 analogues: a novel class of potent regulators of cell growth and immune responses
7. 1-alpha, 25(OH)2D3 increases intracellular calcium in human keratinocytes
8. Interaction 1,25-dihydroxyvitamin D3 with keratinocytes and fibroblasts from skin of normal subjects and a subject with vitamin D dependent rickets type II: a model for study of the mode of action 1,25-dihydroxyvitamin D3
9. A multicentre comparative study of calcipotriol and betamethasone 17-valerate in patients with psoriasis vulgaris
10. Calcipotriol and hypercalcemia
11. Nuclear uptake of 1,25-dihydroxy cholecalciferol in dispersed fibroblasts cultured from normal human skin
12. Demonstration of 1,25-dihydroxyvitamin D3 receptor in human skin biopsies
13. Vitamin D metabolism in psoriasis before and after phototherapy
14. Vitamin D receptors: nature and function
15. A double-blind placebo-controlled trial of topical 1,25-dihydroxycalciferol in psoriasis
16. Topically applied and orally administered 1,25-dihydroxyvitamin D3 is a novel, safe, effective therapy for the treatment of psoriasis: a three year experience and histologic analysis
17. Epidermal cytokeratin levels during oral 1-alphahydroxyvitamin D3 treatment for psoriasis
18. Regulation of terminal differentiation of mouse cultured epidermal cells by 1,25-dihydroxyvitamin D3
19. Successful treatment of psoriasis with topical application of the active vitamin D3 analogue, 1,24-dihydroxycholecalciferol
20. Calcipotriol (MC 903): pharmaco-kinetics in rats and biological activities of metabolites. A comparative study with 1,25(OH)2D3
21. Regulation of epidermal growth factor receptor levels by 1,25-dihydroxyvitamin D3 in human breast cancer cells
22. Treatment of psoriasis by the topical application of the novel cholecaliferol analogue calcipotriol (MC 903)
23. Long-term efficacy and tolerability of topical calcipotriol in psoriasis
24. Calcipotriol (CM 903), a novel vitamin D3 analogue stimulates terminal differentiation and inhibits proliferation of cultured human keratinocytes
25. Improvement of psoriasis by a topical vitamin D3 analogue (MC 903) in a double-blind study
26. Double-blind, right-left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris
27. Treatment of chronic plaque psoriasis by 1-alpha,25-dihydroxyvitamin D3 ointment
28. Efficacy of 1,25-dihydroxyvitamin D3 (calcitriol) in the treatment of psoriasis vulgaris: an open study
29. Comparative effects of a novel vitamin D analogue MC 903 and 1,25-dihydroxyvitamin D3 on alkaline phosphatase activity osteocalcin and DNA synthesis by human osteoblastic cells in culture
30. Growth inhibitory effects of 1,25-dihydroxyvitamin D3 on normal human keratinocytes cultured in serum-free medium
31. Effect of 1,24R-dihydroxyvitamin D3 on the growth of human keratinocytes
32. 1,24R-dihydroxyvitamin D3, a novel active form of vitamin D3 with high activity for inducing epidermal differentiation but decreased hypercalcemic activity
33. 1,25(OH)2D3 enhances antiproliferative effect and transcription of TGF-beta 1 on human keratinocytes
34. Cultured psoriatic fibroblasts from involved and uninvolved sites have partial, but not absolute resistance to the proliferation-inhibition activity of 1,25-dihydroxyvitamin D3
35. Expression of 1,25-dihydroxyvitamin D3 receptors in normal and psoriatic skin
36. A patient with psoriasis cured by 1-alpha-hydroxyvitamin D3
37. An open study of vitamin D3 treatment in psoriasis vulgaris
38. Inverse relationship between serverity of psoriasis and serum 1,25-dihydroxyvitamin D level
39. Effect of calcipotriol on psoriasis: a double-blind, placebo-controlled study of calcipotriol (MC 903) and calcium metabolism
40. 1-alpha,25-dihydroxyvitamin D3 and a novel vitamin D analogue MC 903 are potent inhibitors of human interleukin-1 in vitro
41. 1,25-dihydroxyvitamin D3 inhibits gamma-interferon synthesis by normal peripheral blood lymphocytes
42. Regulation of lymphokine productin and T lymphocyte activation by 1,25-dihydroxyvitamin D3: specific inhibition at level of messenger RNA
43. Psoriasis exaberbated by hypoparathyrdism with hypocalcemia
44. Effect of 1,25-dihydroxyvitamin D3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes growth in serum-free conditions
45. A novel approach for the evaluation and treatment of psoriasis
46. Abnormal vitamin D metabolism in patients with psoriasis
47. Efficacy of topical treatment in psoriasis with MC 903, a new vitamin D analogue
48. Hypocalcemia-induced pustular psoriasis of von Zumbusch
49. Target cells for 1,25-dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary and parathyroid
50. Successful treatment of psoriasis with topical application of the active vitamin D3 analog, 1 alpha, 24-dihydroxycholecaliferol
51. Agonist/inositol triphosphate-induced release of calcium from murine keratinocytes: a possible link with keratinocytes differentiation
52. A double-blind study of topical 1,25-dihydroxyvitamin D3 in psoriasis
53. Immunological properties of 1,25-dihydroxyvitamin D3 analogues: a strong effect on the prolongation of mouse skin allograft survival